PMID- 30480801 OWN - NLM STAT- MEDLINE DCOM- 20200413 LR - 20211204 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 234 IP - 6 DP - 2019 Jun TI - MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. PG - 9577-9591 LID - 10.1002/jcp.27645 [doi] AB - Cervical cancer is common cancer among women with high morbidity. MicroRNAs (miRs) are involved in the progression and development of cervical cancer. This study aimed to explore the effect of miR-99b-5p (miR-99b) on invasion and migration in cervical cancer through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) signaling pathway. The microarray-based analysis was used to screen out differentially expressed miRNAs. Expression of miR-99b, PI3K, AKT, mTOR, and ribosomal protein S6 kinase (p70S6K) was determined in both cervical cancer tissues and paracancerous tissues. Next, alteration of miR-99b expression in cervical cancer was conducted to evaluate levels of PI3K, AKT, mTOR, p70S6K matrix metallopeptidase 2, epithelial cell adhesion molecule, and intercellular adhesion molecule 1, as well as the effect of miR-99b on cell proliferation, invasion, migration, cell cycle distribution, and apoptosis. The results demonstrated that miR-99b expression was decreased and levels of PI3K, AKT, mTOR, and p70S6K were elevated in cervical cancer tissues. More important, overexpressed miR-99b repressed the PI3K/AKT/mTOR signaling pathway, inhibited cell proliferation, invasion, and migration, blocked cell cycle entry, and promoted apoptosis in cervical cancer. These results indicate that miR-99b attenuates the migration and invasion of human cervical cancer cells through downregulation of the PI3K/AKT/mTOR signaling pathway, which provides a therapeutic approach for cervical cancer treatment. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Li, Yong-Jie AU - Li YJ AUID- ORCID: 0000-0001-5483-0489 AD - Department of Obstetrics and Gynecology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. FAU - Wang, Yue AU - Wang Y AD - Department of Obstetrics and Gynecology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. FAU - Wang, Yi-Ying AU - Wang YY AD - Department of Obstetrics and Gynecology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China. LA - eng PT - Journal Article PT - Retracted Publication DEP - 20181127 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (MIRN99 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Messenger) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM RIN - J Cell Physiol. 2022 Mar;237(3):2008. PMID: 34287878 MH - Adult MH - Aged MH - Apoptosis/genetics MH - Base Sequence MH - Cell Cycle MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - Down-Regulation/genetics MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - MicroRNAs/genetics/*metabolism MH - Middle Aged MH - Neoplasm Invasiveness MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Proto-Oncogene Proteins c-akt/*metabolism MH - RNA, Messenger/genetics/metabolism MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/*metabolism MH - Up-Regulation/genetics MH - Uterine Cervical Neoplasms/*genetics/*pathology OTO - NOTNLM OT - PI3K/AKT/mTOR OT - cell invasion OT - cell migration OT - cervical cancer OT - microRNA-99b OT - signaling pathway EDAT- 2018/11/28 06:00 MHDA- 2020/04/14 06:00 CRDT- 2018/11/28 06:00 PHST- 2018/03/22 00:00 [received] PHST- 2018/10/02 00:00 [accepted] PHST- 2018/11/28 06:00 [pubmed] PHST- 2020/04/14 06:00 [medline] PHST- 2018/11/28 06:00 [entrez] AID - 10.1002/jcp.27645 [doi] PST - ppublish SO - J Cell Physiol. 2019 Jun;234(6):9577-9591. doi: 10.1002/jcp.27645. Epub 2018 Nov 27.